Wolfe Research initiated coverage of Albemarle with a Peer Perform rating as part of a broader research note on Chemicals, Agriculture and Packaging names. There is little reason to suspect cost curve support for cratering carbonate/hydroxide prices, the analyst tells investors in a research note. Albemarle is well-positioned with a premium diverse, low-cost asset base, the firm added.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on ALB: